Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mao Uematsu
Institutions:
Tokyo Metropolitan Komagome Hospital,
National Cancer Center Hospital East
Observed institutions:
Tokyo Metropolitan Komagome Hospital,
Juntendo University,
National Cancer Center Hospital East
ORCID:
0009-0003-6566-5943
Observed ORCID:
0009-0003-6566-5943
OpenAlex ID:
A5114054990
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non–Small Cell Lung Cancer
2024
·
Yoko Tsukita
, Takehiro Tozuka
, et al.
·
JAMA Oncology
·
80
PDF
Clinicopathological Factors Related to Recurrence Patterns of Resected Non-Small Cell Lung Cancer
2020
·
Reiko Shimizu
, Tomomari Kinoshita
, et al.
·
Journal of Clinical Medicine
·
25
PDF
First-line immune checkpoint inhibitors alone or in combination with chemotherapy in real-life elderly patients with advanced non-small cell lung cancer (NEJ057).
2023
·
Mao Uematsu
, Yoko Tsukita
, et al.
·
Journal of Clinical Oncology
·
12
Feasibility of intraoperative diagnosis of lung adenocarcinoma in situ to avoid excessive resection
2021
·
Toshiyuki Shima
, Tomonari Kinoshita
, et al.
·
Journal of Thoracic Disease
·
11
PDF
Lymphatic permeation and vascular invasion should not be integrated as lymphovascular invasion in lung adenocarcinoma
2021
·
Yusuke Sugita
, Tomonari Kinoshita
, et al.
·
General Thoracic and Cardiovascular Surgery
·
11
How long is cessation of preoperative smoking required to improve postoperative survival of patients with pathological stage I non-small cell lung cancer?
2020
·
Toshiyuki Shima
, Tomonari Kinoshita
, et al.
·
Translational Lung Cancer Research
·
6
PDF
Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report
2019
·
Mao Uematsu
, Yusuke Kanemasa
, et al.
·
Case Reports in Oncology
·
5
The impact of the COVID ‐19 pandemic on perioperative chemotherapy for breast cancer
2023
·
Kaede Baba
, Megumi Kawamoto
, et al.
·
Cancer Medicine
·
3
PDF
Efficacy of perioperative pembrolizumab for triple-negative breast cancer with apocrine feature or metaplastic carcinoma
2026
·
Nobuyuki Takahashi
, Chikako Funasaka
, et al.
·
The Oncologist
·
2
Digitally quantified area of residual tumor after neoadjuvant chemotherapy in HER2-positive breast cancer
2025
·
Mao Uematsu
, Hiromichi Nakajima
, et al.
·
Breast Cancer
·
2
PDF
Safety of immune checkpoint inhibitors after proton beam therapy in head and neck mucosal melanoma: a case series
2023
·
Mao Uematsu
, Hiromichi Nakajima
, et al.
·
Melanoma Research
·
2
Impact of platinum-free interval and bevacizumab on second-line chemotherapy following progression on first-line PARP inhibitor maintenance in advanced ovarian cancer: A retrospective cohort study
2025
·
Miki Hayakawa
, Hiromichi Nakajima
, et al.
·
Gynecologic Oncology
·
1
PDF
Peripheral Blood Eosinophil Count Optimizes Pembrolizumab-Based Immunotherapy in The First-Line Setting of Advanced or Recurrent Non-Small Cell Lung Cancer
2021
·
Mao Uematsu
, Kosuke Narita
, et al.
·
Research Square
·
1
PDF
Tracheobronchial and Pulmonary Amyloidosis Mimicking Pulmonary Metastases in a Patient With Lung Adenocarcinoma
2020
·
Mao Uematsu
, Tomonari Kinoshita
, et al.
·
JTO Clinical and Research Reports
·
1
PDF
Treatment sequence after first-line immunotherapy in older adults with advanced NSCLC (NEJ057)
2026
·
Kohei Kushiro
, Yoko Tsukita
, et al.
·
International Journal of Clinical Oncology
Second Androgen Receptor Signaling Inhibitor as a Control Arm in Clinical Trials for Metastatic Castration-Resistant Prostate Cancer: A Single-Center, Retrospective Cohort Study
2026
·
Mao Uematsu
, Hiromichi Nakajima
, et al.
·
SSRN Electronic Journal
Excellent Response to Trastuzumab Deruxtecan of a Large Medullary Metastasis from Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Case Report
2025
·
Aoi Kuroda
, Mao Uematsu
, et al.
·
Case Reports in Oncology
The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer
2025
·
Shu Kato
, Kaede Baba
, et al.
·
Cancer Medicine
MO69-5 Contribution of neuroendocrine differentiation to prognosis in extrapulmonary small cell or neuroendocrine carcinoma
2023
·
Nobuyuki Takahashi
, Kanako Mamishin
, et al.
·
Annals of Oncology
A study on oligo-progression after durvalumab plus platinum-etoposide for ES-SCLC.
2023
·
Kageaki Watanabe
, Kazuhito Misawa
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
20
Citation count:
162
H-index:
6
I10-index:
5
Year
Topic
Type